乳房病変位置特定市場は、2021年の2億4400万ドルから2026年までに3億500万ドルに達し、予測期間中のCAGRは4.6％と予想されます。乳がんの位置特定市場の主な成長要因としては、乳がんの発生率の上昇、乳がんスクリーニングプログラムの数の増加、保険適応シナリオの改善が挙げられます。また、高齢者人口の増加とライフスタイルの変化が全体的な癌発生の可能性を高めていることも一つの要因です。さらに、乳がん手術件数の増加と乳がんの早期発見に対する意識の高まりが、この市場の成長を支えています。
乳房病変位置特定市場を含むさまざまな業界でCOVID-19のパンデミックとそれが引き起こしたロックダウンの影響が明らかになっています。特に中国、米国、ヨーロッパのいくつかの国（ロシア、イタリア、スペインなど）など、COVID-19の発生率が高い国では、さまざまなセクターの全体的な成長に大きな影響があります。
乳房生検市場の事業は損失を生じ、その傾向は2020年12月まで続きました。規制やガイドラインの不利な変更が、この業界の成長を妨げています。世界中の主要な規制当局（CDC、WHO、MHRA、TGA、EMAなど）は、乳がん患者は健康な成人よりもCOVID-19感染のリスクが高いことを確認しています。したがって、特に低リスクの患者の場合、ほとんどのスクリーニングおよび位置特定手順が患者と介護者の間の非常に緊密な接触を必要とすることを考慮して、スクリーニング、診断検査、および外科手術は病院および乳がんセンターで制限または延期されています。その結果、2020年の乳がんの診断および治療市場に混乱が生じました。
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 29)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.4 SCOPE OF THE STUDY
1.4.1 MARKETS COVERED
FIGURE 1 GLOBAL BREAST LESION LOCALIZATION MARKET
1.4.2 YEARS CONSIDERED FOR THE STUDY
1.5 CURRENCY
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 33)
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 3 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS
2.2 MARKET SIZE ESTIMATION
FIGURE 6 SUPPLY SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 7 REVENUE SHARE ANALYSIS ILLUSTRATION:
FIGURE 8 REVENUE ANALYSIS OF THE TOP FOUR COMPANIES: BREAST LESION LOCALIZATION MARKET (2020)
FIGURE 9 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE BREAST LESION LOCALIZATION MARKET (2021-2026)
FIGURE 10 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS
FIGURE 11 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 12 MARKET DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: BREAST LESION LOCALIZATION MARKET
2.7 LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
3 EXECUTIVE SUMMARY (Page No. - 48)
FIGURE 13 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021 VS. 2026 (THOUSAND PROCEDURES)
FIGURE 14 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 15 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021 VS. 2026 (THOUSAND PROCEDURES)
FIGURE 16 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 17 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021 VS. 2026 (THOUSAND PROCEDURES)
FIGURE 18 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2021 VS. 2026 (USD MILLION)
FIGURE 19 GEOGRAPHIC ANALYSIS: GLOBAL BREAST LESION LOCALIZATION MARKET (BASED ON PROCEDURE)
FIGURE 20 GEOGRAPHIC ANALYSIS: GLOBAL BREAST LESION LOCALIZATION MARKET (BASED ON VALUE)
4 PREMIUM INSIGHTS (Page No. - 56)
4.1 BREAST LESION LOCALIZATION MARKET OVERVIEW
FIGURE 21 RISING AWARENESS TO DRIVE MARKET GROWTH
4.2 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE
FIGURE 22 WIRE LOCALIZATION TO HOLD THE LARGEST SHARE OF THE ASIA PACIFIC BREAST LESION LOCALIZATION MARKET IN 2020
4.3 BREAST LESION LOCALIZATION MARKET (BASED ON VALUE): GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 23 APAC COUNTRIES TO WITNESS THE HIGHEST GROWTH IN THE BREAST LESION LOCALIZATION MARKET DURING THE FORECAST PERIOD
4.4 BREAST LESION LOCALIZATION MARKET, BY REGION
FIGURE 24 NORTH AMERICA TO DOMINATE THE BREAST LESION LOCALIZATION MARKET TILL 2026
4.5 BREAST LESION LOCALIZATION MARKET: DEVELOPED VS. DEVELOPING MARKETS (THOUSAND PROCEDURES)
FIGURE 25 DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE IN THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 61)
5.1 MARKET DYNAMICS
FIGURE 26 BREAST LESION LOCALIZATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.1.1 MARKET DRIVERS
5.1.1.1 Increasing incidence of breast cancer
TABLE 2 TOP 10 COUNTRIES WITH THE HIGHEST INCIDENCE OF BREAST CANCER, 2020
FIGURE 27 ESTIMATED GLOBAL NUMBER OF NEW CASES OF BREAST CANCER FROM 2020-2040
5.1.1.2 Growing rate of the aging population
5.1.1.3 Increasing awareness on the early detection of breast cancer
5.1.2 MARKET RESTRAINTS
5.1.2.1 Uncertainty in regulatory approval procedures
5.1.3 OPPORTUNITIES
5.1.3.1 Emerging economies offer high growth potential
5.1.3.2 Increasing adoption of technologically advanced localization procedures
5.1.4 CHALLENGES
5.1.4.1 Shortage of oncologists
6 INDUSTRY INSIGHTS (Page No. - 68)
6.1 INDUSTRY TRENDS
6.1.1 ELECTROMAGNETIC WAVES FOR THE LOCALIZATION OF BREAST LESIONS
6.1.2 RADIOFREQUENCY IDENTIFICATION IN BREAST LESION LOCALIZATION
6.1.3 MACHINE LEARNING ALGORITHMS FOR COMPUTER-AIDED BREAST LESION DETECTION
6.2 IMPACT OF COVID-19 ON THE BREAST LESION LOCALIZATION MARKET: RESTRUCTURING OF BREAST CANCER CARE
6.3 VALUE CHAIN ANALYSIS
6.4 REIMBURSEMENT ANALYSIS
TABLE 3 MEDICARE REIMBURSEMENT FOR BREAST LESION LOCALIZATION METHODS
6.5 TECHNOLOGY ANALYSIS
6.5.1 KEY TECHNOLOGIES
6.5.1.1 Wire guided localization (WL)
6.5.1.2 Carbon making
6.5.1.3 Radio-guided occult lesion localization (ROLL)
6.5.1.4 Radioactive seed localization (RSL)
6.5.1.5 Magnetic seed localization (MSL)
6.5.1.6 Radio frequency reflector (RFR)
6.5.2 COMPLEMENTARY TECHNOLOGIES
6.5.2.1 Mammography
6.5.2.2 3D Mammography or Tomosynthesis
6.5.2.3 Magnetic resonance imaging
6.5.2.4 Ultrasound
6.5.3 ADJACENT TECHNOLOGIES
6.5.3.1 Computer vision and artificial intelligence
6.6 PORTER’S FIVE FORCES ANALYSIS
TABLE 4 BREAST LESION LOCALIZATION MARKET: PORTER’S FIVE FORCES ANALYSIS
6.6.1 INTENSITY OF COMPETITIVE RIVALRY
6.6.2 BARGAINING POWER OF SUPPLIERS
6.6.3 BARGAINING POWER OF BUYERS
6.6.4 THREAT OF SUBSTITUTES
6.6.5 THREAT OF NEW ENTRANTS
6.7 REGULATORY ANALYSIS
6.7.1 NORTH AMERICA
6.7.1.1 US
TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
6.7.1.2 Canada
TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 8 BREAST LESION LOCALIZATION DEVICES CLASSIFICATION ACCORDING TO THE GOVERNMENT OF CANADA
6.7.2 EUROPE
FIGURE 28 EUROPE: CLASS III MEDICAL DEVICES
6.7.3 ASIA PACIFIC
6.7.3.1 India
6.8 PATENT ANALYSIS
6.8.1 PATENT PUBLICATION TRENDS FOR BREAST LESIONS
FIGURE 29 PATENT PUBLICATION TRENDS (JANUARY 2011-DECEMBER 2021)
6.8.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 30 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR BREAST LESION PATENTS (JANUARY 2011-DECEMBER 2021)
FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR BREAST LESION PATENTS (JANUARY 2011-DECEMBER 2021)
7 BREAST LESION LOCALIZATION MARKET, BY TYPE (Page No. - 85)
7.1 INTRODUCTION
TABLE 9 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 10 BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
7.2 COVID-19 IMPACT ON THE BREAST LESION LOCALIZATION MARKET, BY TYPE
7.3 WIRE LOCALIZATION
7.3.1 WIRE LOCALIZATION SEGMENT TO COMMAND THE LARGEST SHARE OF THE BREAST LESION LOCALIZATION MARKET
TABLE 11 WIRE LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
TABLE 12 WIRE LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.4 RADIOISOTOPE LOCALIZATION
TABLE 13 RADIOISOTOPE LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 14 RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 15 RADIOISOTOPE LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
TABLE 16 RADIOISOTOPE LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.4.1 RADIOGUIDED OCCULT LESION LOCALIZATION (ROLL)
7.4.1.1 ROLL to result in shorter operating times, higher rates of tumor-free margins, and lower rates of re-operation
TABLE 17 RADIOGUIDED OCCULT LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
TABLE 18 RADIOGUIDED OCCULT LESION LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.4.2 RADIOACTIVE SEED LOCALIZATION (RSL)
7.4.2.1 Reduction in re-excision rates, decreased operative time, and long half-life of RSL to drive market growth
TABLE 19 RADIOACTIVE SEED LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
TABLE 20 RADIOACTIVE SEED LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.5 MAGNETIC LOCALIZATION
7.5.1 MAGNETIC LOCALIZATION TECHNIQUE TO INCREASE WORKFLOW EFFICIENCY AND COST-EFFECTIVENESS, ELIMINATE ISSUES RELATED TO NONRADIOACTIVE TECHNOLOGY, AND IMPROVE SURGICAL PLANNING
TABLE 21 MAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
TABLE 22 MAGNETIC LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.6 ELECTROMAGNETIC LOCALIZATION
7.6.1 ELECTROMAGNETIC LOCALIZATION TO MAKE SMALLER INCISIONS TO BE MORE PRECISE AND SAVE MORE OF THE NORMAL TISSUE DURING SURGERIES
TABLE 23 ELECTROMAGNETIC LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
TABLE 24 ELECTROMAGNETIC LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
7.7 OTHER LOCALIZATION METHODS
TABLE 25 OTHER LOCALIZATION METHODS MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
TABLE 26 OTHER LOCALIZATION PRODUCTS MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
8 BREAST LESION LOCALIZATION MARKET, BY USAGE (Page No. - 103)
8.1 INTRODUCTION
TABLE 27 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 28 BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
8.2 BREAST BIOPSY
8.2.1 BREAST BIOPSY SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE BREAST LESION LOCALIZATION MARKET BY USAGE
TABLE 29 BREAST LESION LOCALIZATION MARKET FOR BREAST BIOPSY, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
TABLE 30 BREAST LESION LOCALIZATION MARKET FOR BREAST BIOPSY, BY COUNTRY, 2019-2026 (USD MILLION)
8.3 BREAST CONSERVATION (LUMPECTOMY)
8.3.1 INCREASING ADOPTION OF BREAST CONSERVATION THERAPY TO DRIVE THE GROWTH OF BREAST LESION LOCALIZATION MARKET
TABLE 31 BREAST LESION LOCALIZATION MARKET FOR BREAST CONSERVATION, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
TABLE 32 BREAST LESION LOCALIZATION MARKET FOR BREAST CONSERVATION, BY COUNTRY, 2019-2026 (USD MILLION)
9 BREAST LESION LOCALIZATION MARKET, BY REGION (Page No. - 110)
9.1 INTRODUCTION
FIGURE 32 NUMBER OF BREAST CANCER CASES VS NUMBER OF DEATHS IN 2020 (IN THOUSANDS)
TABLE 33 BREAST LESION LOCALIZATION MARKET, BY REGION, 2019-2026 (THOUSAND PROCEDURES)
TABLE 34 BREAST LESION LOCALIZATION MARKET, BY REGION, 2019-2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 33 NORTH AMERICA: NUMBER OF BREAST CANCER CASES 2020 (IN THOUSANDS)
TABLE 35 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
TABLE 36 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 37 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 38 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 39 NORTH AMERICA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 40 NORTH AMERICA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 41 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 42 NORTH AMERICA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.2.1 US
TABLE 43 US: KEY MACROINDICATORS
TABLE 44 US: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 45 US: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 46 US: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 47 US: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 48 US: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 49 US: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.2.2 CANADA
TABLE 50 CANADA: KEY MACROINDICATORS
TABLE 51 CANADA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 52 CANADA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 53 CANADA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 54 CANADA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 55 CANADA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 56 CANADA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.3 EUROPE
FIGURE 35 EUROPE: NUMBER OF BREAST CANCER CASES, 2020 (IN THOUSANDS)
TABLE 57 EUROPE: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
TABLE 58 EUROPE: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 59 EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 60 EUROPE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 61 EUROPE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 62 EUROPE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 63 EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 64 EUROPE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.3.1 GERMANY
TABLE 65 GERMANY: KEY MACROINDICATORS
TABLE 66 GERMANY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 67 GERMANY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 68 GERMANY: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 69 GERMANY: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 70 GERMANY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 71 GERMANY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.3.2 FRANCE
TABLE 72 FRANCE: KEY MACROINDICATORS
TABLE 73 FRANCE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 74 FRANCE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 75 FRANCE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 76 FRANCE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 77 FRANCE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 78 FRANCE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.3.3 UK
TABLE 79 UK: KEY MACROINDICATORS
TABLE 80 UK: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 81 UK: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 82 UK: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 83 UK: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 84 UK: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 85 UK: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.3.4 ITALY
TABLE 86 ITALY: KEY MACROINDICATORS
TABLE 87 ITALY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 88 ITALY: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 89 ITALY: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 90 ITALY: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 91 ITALY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 92 ITALY: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.3.5 SPAIN
TABLE 93 SPAIN: KEY MACROINDICATORS
TABLE 94 SPAIN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 95 SPAIN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 96 SPAIN: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 97 SPAIN: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 98 SPAIN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 99 SPAIN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 100 ROE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 101 ROE: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 102 ROE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 103 ROE: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 104 ROE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 105 ROE: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 37 APAC: NUMBER OF BREAST CANCER CASES, 2020 (IN THOUSANDS)
TABLE 106 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (THOUSAND PROCEDURES)
TABLE 107 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
TABLE 108 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 109 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 110 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 111 ASIA PACIFIC: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 112 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 113 ASIA PACIFIC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.4.1 CHINA
TABLE 114 CHINA: KEY MACROINDICATORS
TABLE 115 CHINA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 116 CHINA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 117 CHINA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 118 CHINA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 119 CHINA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 120 CHINA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.4.2 JAPAN
TABLE 121 JAPAN: KEY MACROINDICATORS
TABLE 122 JAPAN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 123 JAPAN: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 124 JAPAN: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 125 JAPAN: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 126 JAPAN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 127 JAPAN: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.4.3 INDIA
TABLE 128 INDIA: KEY MACROINDICATORS
TABLE 129 INDIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 130 INDIA: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 131 INDIA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 132 INDIA: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 133 INDIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 134 INDIA: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.4.4 REST OF APAC
TABLE 135 ROAPAC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 136 ROAPAC: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 137 ROAPAC: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 138 ROAPAC: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 139 ROAPAC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 140 ROAPAC: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
9.5 REST OF THE WORLD
TABLE 141 ROW: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 142 ROW: BREAST LESION LOCALIZATION MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 143 ROW: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 144 ROW: RADIOISOTOPE LOCALIZATION METHODS MARKET, BY TYPE, 2019-2026 (USD MILLION)
TABLE 145 ROW: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (THOUSAND PROCEDURES)
TABLE 146 ROW: BREAST LESION LOCALIZATION MARKET, BY USAGE, 2019-2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 181)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES
10.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
FIGURE 39 REVENUE ANALYSIS OF THE TOP PLAYERS IN THE BREAST LESION LOCALIZATION MARKET
10.4 MARKET SHARE ANALYSIS
FIGURE 40 GLOBAL BREAST LESION LOCALIZATION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
10.5 COMPANY EVALUATION QUADRANT
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
FIGURE 41 BREAST LESION LOCALIZATION MARKET: COMPANY EVALUATION QUADRANT (2020)
10.6 COMPANY EVALUATION QUADRANT FOR START-UPS
10.6.1 PROGRESSIVE COMPANIES
10.6.2 DYNAMIC COMPANIES
10.6.3 STARTING BLOCKS
10.6.4 RESPONSIVE COMPANIES
FIGURE 42 BREAST LESION LOCALIZATION MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020)
10.7 COMPANY PRODUCT FOOTPRINT
TABLE 147 PRODUCT PORTFOLIO ANALYSIS: BREAST LESION LOCALIZATION MARKET
10.8 GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE BREAST LESION LOCALIZATION MARKET
TABLE 148 GEOGRAPHIC REVENUE MIX: BREAST LESION LOCALIZATION MARKET (2020)
10.9 COMPETITIVE SCENARIO
10.9.1 DEALS
TABLE 149 DEALS
10.9.2 PRODUCT LAUNCHES AND UPGRADES
TABLE 150 PRODUCT LAUNCHES AND UPGRADES
10.10 BREAST LESION LOCALIZATION METHODS: COMPARATIVE ANALYSIS
10.11 BREAST LESION LOCALIZATION METHODS: COMPARATIVE ANALYSIS
10.12 BREAST LESION LOCALIZATION METHODS: SELECTION CRITERIA EVALUATION
10.13 QUALITATIVE ASSESSMENT OF REPLACEMENT TRENDS
11 COMPANY PROFILES (Page No. - 196)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 HOLOGIC, INC.
TABLE 151 HOLOGIC, INC.: BUSINESS OVERVIEW
FIGURE 46 HOLOGIC, INC.: COMPANY SNAPSHOT (2020)
11.1.2 BECTON, DICKINSON AND COMPANY
TABLE 152 BECTON, DICKINSON, AND COMPANY: BUSINESS OVERVIEW
FIGURE 47 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
11.1.3 MERIT MEDICAL SYSTEMS
TABLE 153 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW
FIGURE 48 MERIT MEDICAL SYSTEMS, INC.: COMPANY SNAPSHOT (2020)
11.1.4 LEICA BIOSYSTEMS NUSSLOCH GMBH
TABLE 154 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 49 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.5 ARGON MEDICAL DEVICES
TABLE 155 ARGON MEDICAL DEVICES: BUSINESS OVERVIEW
11.1.6 LAURANE MEDICAL LLC
TABLE 156 LAURANE MEDICAL LLC: BUSINESS OVERVIEW
11.1.7 ENDOMAGNETICS LTD. (ENDOMAG)
TABLE 157 ENDOMAGNETICS LIMITED: BUSINESS OVERVIEW
11.1.8 INTRAMEDICAL IMAGING, LLC
TABLE 158 INTRAMEDICAL IMAGING, LLC: BUSINESS OVERVIEW
11.1.9 ISOAID
TABLE 159 ISOAID: BUSINESS OVERVIEW
11.1.10 SURGICEYE GMBH
TABLE 160 SURGICEYE GMBH: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 RANFAC CORP.
TABLE 161 RANFAC CORP.: BUSINESS OVERVIEW
11.2.2 MERMAID MEDICAL GROUP
TABLE 162 MERMAID MEDICAL GROUP: BUSINESS OVERVIEW
11.2.3 IZI MEDICALPRODUCTS, LLC
TABLE 163 IZI MEDICAL PRODUCTS, LLC: BUSINESS OVERVIEW
11.2.4 MATEK MEDIKAL
TABLE 164 MATEK MEDIKAL: BUSINESS OVERVIEW
11.2.5 TSUNAMI MEDICAL SRL
TABLE 165 TSUNAMI MEDICAL SRL: BUSINESS OVERVIEW
11.2.6 BPB MEDICA
TABLE 166 BPB MEDICA: BUSINESS OVERVIEW
11.2.7 SIRIUS MEDICAL SYSTEMS B.V.
TABLE 167 SIRIUS MEDICAL SYSTEMS B.V.: BUSINESS OVERVIEW
11.2.8 MOLLI SURGICAL INC.
TABLE 168 MOLLI SURGICAL INC.: BUSINESS OVERVIEW
11.2.9 STERYLAB S.R.L.
TABLE 169 STERYLAB S.R.L.: BUSINESS OVERVIEW
11.2.10 CP MEDICAL
TABLE 170 CP MEDICAL: BUSINESS OVERVIEW
11.2.11 MDL SRL
TABLE 171 MDL SRL: BUSINESS OVERVIEW
11.2.12 BIOMEDICAL SRL
TABLE 172 BIOMEDICAL SRL: BUSINESS OVERVIEW
11.2.13 ELUCENT MEDICAL
TABLE 173 ELUCENT MEDICAL: BUSINESS OVERVIEW
11.2.14 VIGEO SRL
TABLE 174 VIGEO SRL: BUSINESS OVERVIEW
11.2.15 MEDAX MEDICAL DEVICES
TABLE 175 MEDAX MEDICAL DEVICES: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 232)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 RELATED REPORTS
12.4 AUTHOR DETAILS
